# Joe Y. Chang

Source: https://onco.cc/people/joe-chang/  
OnCo record `joe-chang` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Led the trials comparing stereotactic radiotherapy with surgery for operable early lung cancer.

## Summary

Joe Chang led the pooled STARS and ROSEL analysis and the revised STARS trial suggesting stereotactic ablative radiotherapy matches lobectomy for operable stage I NSCLC, results that opened the surgery-versus-SABR debate. He directs thoracic radiation oncology at MD Anderson and studies proton therapy and radiotherapy-immunotherapy combinations.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: radiotherapy; sbrt; lung
- Role: Professor of Radiation Oncology, MD Anderson Cancer Center
- Specialisms: Stereotactic ablative radiotherapy; Proton therapy; Lung cancer; Immunotherapy-radiotherapy combinations

## Sources

- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Chang%20JY%5BAuthor%5D%20stereotactic%20ablative%20lung

## Connected records

- cancers: [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/)
- technologies: [Proton therapy](https://onco.cc/technologies/proton-therapy/), [SBRT / SABR (stereotactic radiotherapy)](https://onco.cc/technologies/sbrt/)
- institutions: [MD Anderson Cancer Center](https://onco.cc/institutions/md-anderson/)

---
JSON: https://onco.cc/api/v1/entities/joe-chang.json